(firstQuint)Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%.

 This is a Phase I, open-label, parallel trial to evaluate Pharmacokinetics, Pharmacodynamics and Safety of Testosterone gel 1% for topic usage in post-menopausal women, Study participants will receive investigational product for 28 consecutive days, once daily, as per the following allocation: 2.

2 mg, 4.

4 mg.

 8.

8 mg or placebo.

.

 Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%@highlight

This is a Phase I, open-label, parallel trial to evaluate Pharmacokinetics, Pharmacodynamics and Safety of Testosterone gel 1% for topic usage in post-menopausal women, for 28 days